NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-190-2014-0-EP-43 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		EP DIV 22157548.3 Pending
NCI E-029-2019-0-HK-11 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION HK CN 62022048432.8 Pending
NCI E-171-2018-8-US-08 Intracellular Genomic Transplant and Methods of Therapy US DIV 17/674,378 Pending
NCI E-166-2018-0-HK-08 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS HK EP 62022048394.0 Pending
NCI E-168-2018-0-US-03 METHODS OF ISOLATING T CELL POPULATIONS US National Stage 17/636,206 Pending
NCI E-174-2018-2-JP-17 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer JP DIV 2022-22792 Pending
NCI E-176-2014-0-IL-64 Anti-Human Papillomavirus 16 E7 T Cell Receptors IL DIV 2055-06-29 Issued
NHLBI E-155-2016-0-US-04 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US CON 17/673,361 11872261 Issued PDF
NIAID E-214-2021-2-PCT-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides PCT PCT COMB PCT/US2022/016600 Expired
NCI E-029-2021-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 PCT PCT PCT/US2022/016561 Expired
NIAID E-214-2021-2-AU-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides AU National Stage 2022224567 Pending
NIAID E-214-2021-2-BR-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides BR National Stage BR112023016402-8 Pending
NIAID E-214-2021-2-IN-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides IN National Stage
NIAID E-214-2021-2-IL-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides IL National Stage 305174 Pending
NIAID E-214-2021-2-CA-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides CA National Stage 3207998 Pending
NIAID E-214-2021-2-CN-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides CN National Stage 202280020122.X Pending
NIAID E-214-2021-2-JP-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides JP National Stage 2023-548865 Pending
NCI E-248-2020-0-US-05 Protein Panels For The Early Diagnosis/Prognosis Of Aggressive Prostate Cancer US National Stage 17/634,626 Pending
NIAID E-191-2023-0-PC-01 METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS AND RELATED TREATMENT METHODS PCT PCT PCT/US2022/015835 Expired
NCI E-040-2012-0-IL-68 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen IL DIV 2071-04-29 Pending
NIAID E-135-2010-0-HK-38 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production HK EP 42022047741.8 Pending
NCI E-126-2019-0-US-03 T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY US National Stage 17/633,414 Pending
NIAID E-037-2021-1-PCT-01 Antibodies Targeting The Spike Protein Of Coronaviruses PCT PCT PCT/US2022/015341 Expired
NCI E-064-2021-0-PCT-03 Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection PCT PCT PCT/US2022/015349 Expired
NCI E-029-2019-0-HK-12 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION HK EP 62022047561.5 Pending
NHGRI E-122-2017-0-US-03 CANCER DETECTION AND CLASSIFICATION US National Stage 17/632,783 Pending
NCI E-040-2012-0-RU-67 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU DIV 2022102579 Pending
NIAID E-241-2014-0-JP-09 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof JP DIV 2022-014647 Pending
NCI E-094-2017-0-JP-01 COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-MESOTHELIN IMMUNOTHERAPY JP DIV 2022-014136 Issued
NIAID E-042-2018-0-US-08 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE US CON 17/590,631 Pending
NHLBI E-163-2019-0-US-04 RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS US National Stage 17/631,600 Pending
NCI E-085-2013-0-JP-31 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR
REACTIVE T CELLS FROM PERIPHERAL BLOOD 		JP DIV 2022-011975 Issued
NCI E-243-2020-0-PCT-02 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER PCT PCT PCT/US2022/014448 Expired
NHLBI E-056-2021-0-PCT-02 A New Molecular Scaffold For Targeting HRpn13 PCT PCT PCT/US2022/014199 Expired
NIAID E-083-2017-0-US-05 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE US CON 17/587,817 Pending
NHLBI E-056-2021-0-US-02 A New Molecular Scaffold For Targeting HRpn13 US National Stage 18/262,941 Pending
NCATS E-077-2020-2-US-02 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS US CON 17/587,070 Pending
NHLBI E-056-2021-0-EP-01 A New Molecular Scaffold For Targeting HRpn13 EP National Stage 22704672.9 Pending
NHLBI E-056-2021-0-AU-01 A New Molecular Scaffold For Targeting HRpn13 AU National Stage 2022212029 Pending
NHLBI E-056-2021-0-CA-01 A New Molecular Scaffold For Targeting HRpn13 CA National Stage 3209597 Pending
NIAID E-540-2013-0-US-12 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION US CON 17/649,133 Pending
NCI E-141-2021-0-US-02 LIQUID BIOPSY TO DETECT CANCER EARLY AND SENSITIVELY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 US ORD 17/586,676 Pending
NCI E-135-2019-0-EP-08 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 EP National Stage 20742583.6 Pending
NCI E-256-2020-0-PCT-04 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS 		PCT PCT PCT/US2022/013946 Expired
NCI E-135-2019-0-KR-15 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 KR National Stage 2022-7002872 Pending
NCI E-266-2011-0-IL-60 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IL DIV 2005-01-29 Issued
NIAID E-196-2022-0-PCT-02 Compositions And Methods For Treating Malaria PCT PCT PCT/US2022/013223 Expired
NCI E-135-2019-0-RU-12 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 RU National Stage 2022101295 Pending
NCI E-240-2015-1-MO-10 Methods of Analyzing Virus-Derived Therapeutics MO CN J/005746 Issued
NCI E-176-2014-0-HK-62 Anti-Human Papillomavirus 16 E7 T Cell Receptors HK CN 42022046605.6 Pending